Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Zepbound comparison to understand how these medications differ in mechanism and results
Combining genetic insights with clinical markers (fasting glucose, body composition, liver and kidney function) helps your provider tailor a more personalized treatment plan
Theoretical concern exists for tumor promotion
Often when a drug is in early development, investigators need healthy volunteers to test the bodys reaction to the compound before administering it to a patient with the condition or disease the drug is meant to target
Unlike some medications that accumulate in kidney tissue, tirzepatide is primarily hepatically metabolized, making it suitable for patients with mild-to-moderate CKD stages
Risk of hypoglycemia Theres a risk of low blood sugar (hypoglycemia) when using GLP-1 agonists
US$ 22.42
US$ 25.71
US$ 28.36
US$ 21.07
US$ 21.95
US$ 26.18
US$ 26.28
US$ 27.96
